Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma

Conditions: Kidney Cancer; Renal Cell Carcinoma; Renal Clear Cell Carcinoma Interventions: Drug: Anlotinib, Everolimus and Tislelizumab Sponsors: Fudan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials